[Federal Register Volume 62, Number 147 (Thursday, July 31, 1997)]
[Notices]
[Pages 41067-41068]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-20160]


-----------------------------------------------------------------------

NATIONAL INSTITUTES OF HEALTH

National Cancer Institute


Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Cancer Institute Special Emphasis Panel (SEP) meetings:

    Name of SEP: Review of R25 (Education Grants) Applications.
    Date: August 14, 1997.
    Time: 2:00 to Adjournment.
    Place: Teleconference, National Cancer Institute, Executive 
Plaza North, Room 611A, 6130 Executive Boulevard, Bethesda, MD 
20892.
    Contact Person: Mary Bell, Ph.D., Scientific Review 
Administrator, National Cancer Institute, NIH, Executive Plaza 
North, Room 611A, 6130 Executive Boulevard, MSC 7410,

[[Page 41068]]

Bethesda, MD 20892-7410, Telephone: 301/496-7978.
    Purpose/Agenda: To evaluate and review responses to request for 
proposal.
    This notice is being published less than 15 days prior to the 
meeting due to the urgent need to meet timing limitations imposed by 
the review and funding cycle.
    Name of SEP: Preclinical Evaluation of Intermediate Endpoints 
and their Modulation by Chemopreventive Agents.
    Date: September 11-12, 1997.
    Time: 9:00 p.m. to 5:00 p.m.
    Place: Ramada Inn-Rockville, 1775 Rockville Pike, Rockville, MD 
20852.
    Contact Person: Lalita Palekar, Ph.D., Scientific Review 
Administrator, National Cancer Institute, NIH, Executive Plaza 
North, Room 622, 6130 Executive Boulevard, MSC 7410, Bethesda, MD 
20892-7410, Telephone: 301/496-7575.
    Purpose/Agenda: To evaluate and review responses to request for 
proposal.
    The meetings will be closed in accordance with the provisions 
set forth in secs. 552b(c)(4) and 552(c)(6), Title 5 U.S.C. 
Applications and the discussions could reveal confidential trade 
secrets or commercial property such as patentable material and 
personal information concerning individuals associated with the 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Program Numbers: 93.393, 
Cancer Cause and Prevention Research; 93.394, Cancer Detection and 
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, 
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
Cancer Research Manpower; 93.399, Cancer Control)

    Dated: July 24, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-20160 Filed 7-30-97; 8:45 am]
BILLING CODE 4140-01-M